Suchergebnisse - "Brufsky, Adam"

PubPharm (27)

1

Real-world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database

enthalten in: International journal of cancer | 2024

von Rugo, H. | Liu, X. | Li, B. | +4

ErratumIn: Int J Cancer. 2024 Mar 30;:. - PMID 38554278

2

Ten-year update : NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer

enthalten in: Journal of the National Cancer Institute | 2023

von Mamounas, E. | Bandos, H. | Rastogi, P. | +13

CommentIn: J Natl Cancer Inst. 2023 Jun 30;:. - PMID 37480258

3

Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer

enthalten in: The oncologist | 2023

von Rugo, H. | Liu, X. | Li, B. | +4

4

P-REALITY X : A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast

enthalten in: Targeted oncology | 2023

von Brufsky, A. | Gallagher, C.

5

Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer : Flatiron Database Analysis

enthalten in: Clinical breast cancer | 2022

von Patt, D. | Liu, X. | Li, B. | +3

6

Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer : Analysis from the US Syapse Learning Health Network

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Law, J. | Mitra, D. | Kaplan, H. | +9

7

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice

enthalten in: Breast cancer research : BCR | 2021

von DeMichele, A. | Cristofanilli, M. | Brufsky, A. | +8

8

Aromatase Inhibitor-Associated Musculoskeletal Syndrome : Understanding Mechanisms and Management

enthalten in: Frontiers in endocrinology | 2021

von Hyder, T. | Marino, C. | Ahmad, S. | +2

9

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2019

von Mamounas, E. | Bandos, H. | Lembersky, B. | +17

CommentIn: Lancet Oncol. 2019 Jan;20(1):8-9. - PMID 30509770

10

Extended adjuvant therapy for early-stage breast cancer : Are there markers for its use?

enthalten in: The breast journal | 2019

von Klar, N. | Brufsky, A.

CommentOn: Breast J. 2019 Jan;25(1):9-15. - PMID 29687661